GSK to acquire Sierra Oncology for US $1.9bn
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Study to evaluate effectiveness of hypoglossal nerve stimulation
Results from the BiologyWorks k(now) molecular test were 99.1% in overall percent agreement with the results of the RT-PCR lab tests
MultiTEP Platform-based vaccine targeting three B cell epitopes of pathological ?-Synuclein simultaneously shows protective efficacy in mouse model of synucleinopathies
The company’s platform technology works like a compression algorithm for molecular testing and has applications in healthcare, pharmaceuticals, agriculture, animal husbandry, food safety, synthetic biology, and molecular biology research
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
The company plans to raise US $ 15 million
Subscribe To Our Newsletter & Stay Updated